OAB patients | Controls | p-value (adjusted for age and sex) | |
---|---|---|---|
Demographics: | |||
No. of subjects | 51 | 30 | |
Age (mean ± SD) | 53.8 ± 11.9 | 54.2 ± 12.3 | 0.98 |
Sex (% females) | 73 % | 57 % | 0.14 |
Race (% white) | 43.1 % | 63.3 % | 0.08 |
Age of diagnosis of OAB (mean ± SD) | 47.5 ± 15.2 | Not applicable | |
% with OAB symptoms less than one year? | 24 % | Not applicable | |
Urinary symptoms: (mean ± SD) | |||
No. of daytime void (see footnote)a | 1.8 ± 1.3 | 0.2 ± 0.6 | <0.001 |
No of nighttime voidb | 2.6 ± 1.1 | 0.9 ± 0.7 | <0.001 |
How often rush to bathroom to void?c | 2.7 ± 0.9 | 0.6 ± 0.7 | <0.001 |
How often does urine leak before getting to the bathroom?d | 2.2 ± 0.9 | 0.3 ± 0.5 | <0.001 |
Validated questionnaires: (mean ± SD) | |||
ICIQ-UI (urinary incontinence, 0–21) | 12.0 ± 4.9 | 1.4 ± 2.0 | <0.001 |
ICIQ-OAB (overactive bladder, 0–16) | 9.3 ± 2.6 | 2.0 ± 1.5 | <0.001 |
OAB-q symptom bother subscale (6–36) | 19.1 ± 6.6 | 2.2 ± 2.8 | <0.001 |
OAB-q quality of life subscale (13–78) | 29.7 ± 16.9 | 2.0 ± 3.0 | <0.001 |
UDI-6 (urogenital distress inventory, 0–24) | 12.6 ± 5.6 | 0.9 ± 1.4 | <0.001 |
IIQ-7 (incontinence impact questionnaire, 0–28) | 8.8 ± 8.2 | 0.1 ± 0.4 | <0.001 |
Medical comorbidities: | |||
Hypertension | 37 % | 33 % | 0.72 |
Diabetes | 8 % | 3 % | 0.31 |
Stroke, transient ischemic attack | 8 % | 7 % | 0.15 |
MI, angina | 0 % | 0 % | 1.00 |